Organization
F. Hoffmann-La Roche AG
6 abstracts
Abstract
New soft tissue sarcoma (STS) transcriptomic clusters to unveil STS subsets with unique biological characteristics and refine the accuracy of overall survival (OS) prediction.Org: Instituto Português de Oncologia de Lisboa Francisco Gentil, Instituto Superior Técnico, Translational Oncobiology Lab, Instituto de Medicina Molecular João Lobo Antunes, F. Hoffmann-La Roche AG,
Abstract
Investigating peripheral blood biomarkers of immune checkpoint inhibitor associated fatigue.Org: Johns Hopkins University School of Medicine, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, F. Hoffmann-La Roche AG, Genentech,
Abstract
The worldwide impact of HER2-targeted treatments in women with breast cancer: An epidemiological modeling study.Org: Genentech Inc., F. Hoffmann-La Roche AG,
Abstract
Patient-derived skin MicroOrganoSpheres and clinical response to immunotherapy.Org: Xilis, Durham Veteran Affairs Medical Center, NC Medical Research, Xilis Inc, Xilis, Inc.,
Abstract
Baseline autoantibody profiling in patients with NSCLC with pre-existing autoimmune diseases or who had received prior anti-PD-1 therapy before enrolling in the TAIL study.Org: Complejo Hospitalario Universitario Insular-Materno Infantil, Oncimmune Germany GmbH, Rochester Regional Health System, F. Hoffmann-La Roche AG, Genentech Inc.,
Abstract
ASSOCIATION OF BIOLOGIC ANTIRHEUMATIC THERAPY WITH THE RISK OF DEVELOPING TYPE 2 DIABETES IN ADULTS WITH RHEUMATOID ARTHRITIS: NEW EVIDENCE FROM REAL WORLD DATA Org: Genentech, F. Hoffmann-La Roche AG, University of Melbourne, QIMR Berghofer Medical Research Institute,